课题基金 / 基金详情

DEATH RECEPTOR SIGNALING PATHWAYS IN T CELL DEVELOPMENT

DEATH RECEPTOR SIGNALING PATHWAYS IN T CELL DEVELOPMENT
T 细胞发育中的死亡受体信号通路
批准号:
6455741
负责人:
Craig Michael Walsh
金额:
$1.49万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
未结题
起止时间:
2001-04-01 至

项目摘要

项目成果

Craig Michael Walsh的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The goal of my research is to elucidate the roles of apoptotic signaling pathways in the development and homeostasis of T cells. Toward this goal, I have produced transgenic mice in which specific components of these pathways have been blocked. In one transgenic line, a dominant-negative form of an adapter molecule known as FADD is expressed in developing thymocytes and mature T lymphocytes. FADD has been shown to mediate apoptotic signaling following ligation of certain nerve growth factor-/tumor necrosis factor-receptor family members. A dominant negative mutant of FADD (FADDdd) interferes with death induction following triggering of these receptors. Surprisingly, FADDdd transgenic T cells appear to undergo normal apoptosis in the thymus, but have defective development and reduced proliferation in response to antigenic stimulation. These paradoxical results suggest that the same mechanisms that control death also control survival and proliferation. Additionally, my research has demonstrated that this control is exerted at the level of the cytokine receptor/Jak/Stat pathway. The research outlined here will attempt to determine the molecular nature of this process in T cell development and homeostasis and to more broadly determine the interplay between death- and cytokine-receptor pathways.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hyperion multi-parameter high-dimensional imaging mass cytometry platform
  • 批准号:
    10193821
  • 项目类别:
  • 资助金额:
    $59.99万
  • 财政年份:
    2021
  • 负责人:
    Craig Michael Walsh
  • 依托单位:
Modulation of T Cell Activation and Tolerance by DRAK2
  • 批准号:
    8093107
  • 项目类别:
  • 资助金额:
    $22.91万
  • 财政年份:
    2010
  • 负责人:
    Craig Michael Walsh
  • 依托单位:
Modulation of T Cell Activation and Tolerance by DRAK2
  • 批准号:
    7917835
  • 项目类别:
  • 资助金额:
    $3.44万
  • 财政年份:
    2009
  • 负责人:
    Craig Michael Walsh
  • 依托单位:
Modulation of T Cell Activation and Tolerance by DRAK2
  • 批准号:
    7430248
  • 项目类别:
  • 资助金额:
    $4.5万
  • 财政年份:
    2007
  • 负责人:
    Craig Michael Walsh
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: